Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study

Heterogeneity in the use of biologics for severe asthma in Europe: a SHARP ERS study

Introduction Treatment with biologics for severe asthma is informed by international and national guidelines and defined by national regulating bodies, but how these drugs are used in real-life is unknown. Materials and methods The European Respiratory Society (ERS) SHARP Clinical Research Collabora...

Full description

Bibliographic Details
Main Authors: Anne-Noelle Frix, Liam G. Heaney, Barbro Dahlén, Florin Mihaltan, Svetlana Sergejeva, Sanja Popović-Grle, Vratislav Sedlak, Lauri Lehtimäki, Arnaud Bourdin, Stephanie Korn, Eleftherios Zervas, Zsuzsanna Csoma, Dora Lúðvíksdóttir, Marcus Butler, Giorgio Walter Canonica, Ineta Grisle, Kristina Bieksiene, Anneke Ten Brinke, Piotr Kuna, Claudia Chaves Loureiro, Natalia M. Nenasheva, Zorica Lazic, Sabina Škrgat, David Ramos-Barbon, Joerg Leuppi, Bilun Gemicioglu, Apostolos Bossios, Celeste M. Porsbjerg, Elisabeth H. Bel, Ratko Djukanovic, Renaud Louis
Format: Article
Language:English
Published: European Respiratory Society 2022-10-01
Series:ERJ Open Research
Online Access:http://openres.ersjournals.com/content/8/4/00273-2022.full

Internet

http://openres.ersjournals.com/content/8/4/00273-2022.full

Similar Items